|
1）Fialkow PJ, Thomas ED, Bryant JI, et al. Leukaemic transformation of engrafted human marrow cells in vivo. Lancet. 1971; 1: 251-5
|
|
|
|
2）Spinelli O, Giussani U, Borleri G, et al. Need for an accurate molecular diagnosis to assess the donor origin of leukemia relapse after allogeneic stem cell transplantation. Haematologica. 2000; 85: 1153-7
|
|
|
|
|
|
3）Hertenstein B, Hambach L, Bacigalupo A, et al. Development of leukemia in donor cells after allogeneic stem cell transplantation--a survey of the European Group for Blood and Marrow Transplantation (EBMT). Haematologica. 2005; 90: 969-75
|
|
|
|
|
|
4）Wang E, Hutchinson CB, Huang Q, et al. Donor cell-derived leukemias/myelodysplastic neoplasms in allogeneic hematopoietic stem cell transplant recipients: a clinicopathologic study of 10 cases and a comprehensive review of the literature. Am J Clin Pathol. 2011; 135: 525-40
|
|
|
|
|
5）Wiseman DH. Donor cell leukemia: a review. Biol Blood Marrow Transplant. 2011; 17: 771-89
|
|
|
|
|
|
6）Sala Torra O, Loeb KR. Donor cell-derived leukemia and myelodysplastic neoplasm: unique forms of leukemia. Am J Clin Pathol. 2011; 135: 501-4
|
|
|
|
|
|
7）Niederwieser DW, Appelbaum FR, Gastl G, et al. Inadvertent transmission of a donorʼs acute myeloid leukemia in bone marrow transplantation for chronic myelocytic leukemia. N Engl J Med. 1990; 322: 1794-6
|
|
|
|
|
|
8）Sala-Torra O, Hanna C, Loken MR, et al. Evidence of donor-derived hematologic malignancies after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2006; 12: 511-7
|
|
|
|
|
|
9）Dickson MA, Papadopoulos EB, Hedvat CV, et al. Acute myeloid leukemia arising from a donor derived premalignant hematopoietic clone: A possible mechanism for the origin of leukemia in donor cells. Leuk Res Rep. 2014; 3: 38-41
|
|
|
|
|
|
10）Sevilla J, Querol S, Molines A, et al. Transient donor cell-derived myelodysplastic syndrome with monosomy 7 after unrelated cord blood transplantation. Eur J Haematol. 2006; 77: 259-63
|
|
|
|
|
|
11）Flynn CM, Kaufman DS. Donor cell leukemia: insight into cancer stem cells and the stem cell niche. Blood. 2007; 109: 2688-92
|
|
|
|
|
|
12）Raaijmakers MH, Mukherjee S, Guo S, et al. Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia. Nature. 2010; 464: 852-7
|
|
|
|
|
|
13）Kim YW, Koo BK, Jeong HW, et al. Defective Notch activation in microenvironment leads to myeloproliferative disease. Blood. 2008; 112: 4628-38
|
|
|
|
|
|
14）Walkley CR, Olsen GH, Dworkin S, et al. A microenvironment-induced myeloproliferative syndrome caused by retinoic acid receptor gamma deficiency. Cell. 2007; 129: 1097-110
|
|
|
|
|
|
15）Zhu X, You Y, Li Q, et al. BCR-ABL1-positive microvesicles transform normal hematopoietic transplants through genomic instability: implications for donor cell leukemia. Leukemia. 2014; 28: 1666-75
|
|
|
|
|
|
16）Yasuda T, Ueno T, Fukumura K, et al. Leukemic evolution of donor-derived cells harboring IDH2 and DNMT3A mutations after allogeneic stem cell transplantation. Leukemia. 2014; 28: 426-8
|
|
|
|
|
|
17）Murata M, Ishikawa Y, Ohashi H, et al. Donor cell leukemia after allogeneic peripheral blood stem cell transplantation: a case report and literature review. Int J Hematol. 2008; 88: 111-5
|
|
|
|
|
18）Shlush LI, Zandi S, Mitchell A, et al. Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia. Nature. 2014; 506: 328-33
|
|
|
|
|
|
19）Busque L, Patel JP, Figueroa ME, et al. Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis. Nat Genet. 2012; 44: 1179-81
|
|
|
|
|
|
20）Xie M, Lu C, Wang J, et al. Age-related mutations associated with clonal hematopoietic expansion and malignancies. Nat Med. 2014; 20: 1472-8
|
|
|
|
|
|
21）Genovese G, Kahler AK, Handsaker RE, et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N Engl J Med. 2014; 371: 2477-87
|
|
|
|
|
|
22）Jaiswal S, Fontanillas P, Flannick J, et al. Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J Med. 2014; 371: 2488-98
|
|
|
|
|